ZDA
BLFS icon

Zweig-DiMenna Associates’s BioLife Solutions BLFS Stock Holding History

Zweig-DiMenna Associates’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,944
Closed -$1.13M – 84
2024
Q1 		$1.13M Sell
60,944
-103,606
-63% -$1.81M 0.1% 105
2023
Q4 		$2.67M Sell
164,550
-16,770
-9% -$214K 0.3% 73
2023
Q3 		$2.5M Sell
181,320
-74,680
-29% -$1.18M 0.3% 81
2023
Q2 		$5.66M Sell
256,000
-76,000
-23% -$1.6M 0.71% 50
2023
Q1 		$7.22M Sell
332,000
-53,000
-14% -$1.19M 0.98% 39
2022
Q4 		$7.01M Buy
385,000
+16,000
+4% +$330K 1.02% 42
2022
Q3 		$8.39M Sell
369,000
-99,361
-21% -$2.13M 1.83% 20
2022
Q2 		$6.47M Buy
468,361
+91,811
+24% +$1.35M 1.23% 32
2022
Q1 		$8.56M Buy
376,550
+59,567
+19% +$1.57M 1.14% 34
2021
Q4 		$11.8M Buy
316,983
+10,650
+3% +$457K 0.95% 45
2021
Q3 		$13M Buy
306,333
+1,250
+0.4% +$60.2K 0.9% 42
2021
Q2 		$13.6M Buy
+305,083
New +$10.7M 0.82% 48

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Zweig-DiMenna Associates's BLFS Position: Q2 2024 in Review

Zweig-DiMenna Associates sold out of BioLife Solutions (BLFS) in Q2 2024, closing a stake of 60,944 shares — an estimated $1.13M sold.

Zweig-DiMenna Associates first reported a position in BLFS in Q2 2021 and held it in 12 quarters. The position peaked at $13.6M in Q2 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q2 2024.

  • Zweig-DiMenna Associates reported no remaining BioLife Solutions position as of Q2 2024 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 60,944 BioLife Solutions shares in Q2 2024, an estimated $1.13M.
  • Zweig-DiMenna Associates first reported a position in BioLife Solutions in Q2 2021 and held it in 12 quarters.
  • Zweig-DiMenna Associates's BioLife Solutions position peaked at $13.6M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2024.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2024, filed 24 Jul 2024.